These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20626844)

  • 21. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?
    Guantai E; Chibale K
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S2. PubMed ID: 21411013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria.
    Mokuolu OA; Bolarinwa OA; Opadiran OR; Ameen HA; Dhorda M; Cheah PY; Amaratunga C; de Haan F; Tindana P; Dondorp AM
    Malar J; 2023 Jun; 22(1):185. PubMed ID: 37330469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.
    Phillips MA; Rathod PK
    Infect Disord Drug Targets; 2010 Jun; 10(3):226-39. PubMed ID: 20334617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
    Pongtavornpinyo W; Yeung S; Hastings IM; Dondorp AM; Day NP; White NJ
    Malar J; 2008 Nov; 7():229. PubMed ID: 18976503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaria, anti malarial drugs and the role of melatonin.
    Srinivasan V; Mohamed M; Zakaria R; Ahmad AH
    Infect Disord Drug Targets; 2012 Oct; 12(5):371-9. PubMed ID: 23082960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
    Mwendera C; de Jager C; Longwe H; Phiri K; Hongoro C; Mutero CM
    Health Res Policy Syst; 2016 Jun; 14(1):41. PubMed ID: 27246503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The co-evolution of people, plants, and parasites: biological and cultural adaptations to malaria.
    Etkin NL
    Proc Nutr Soc; 2003 May; 62(2):311-7. PubMed ID: 14506878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against.
    Krishna S
    Malar J; 2019 Oct; 18(1):339. PubMed ID: 31581951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malaria prophylaxis and treatment: problems, recent developments and perspectives].
    Pradines B; Vial H; Olliaro P
    Med Trop (Mars); 2003; 63(1):79-98. PubMed ID: 12891756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach.
    Canavati SE; Lawford HL; Fatunmbi BS; Lek D; Top-Samphor N; Leang R; Dondorp AM; Huy R; Kazadi WM
    Malar J; 2016 Feb; 15():120. PubMed ID: 26916933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in System Based Study for Anti-Malarial Drug Development Process.
    Yadav BS; Chaturvedi N; Marina N
    Curr Pharm Des; 2019; 25(31):3367-3377. PubMed ID: 31475893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarials: Molecular Drug Targets and Mechanism of Action.
    Achieng AO; Rawat M; Ogutu B; Guyah B; Michael Ong'echa J; J Perkins D; Kempaiah P
    Curr Top Med Chem; 2017; 17(19):2114-2128. PubMed ID: 28137233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of anti-malarial drugs in eliminating malaria.
    White NJ
    Malar J; 2008 Dec; 7 Suppl 1(Suppl 1):S8. PubMed ID: 19091042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in malaria drug discovery.
    Lanteri CA; Johnson JD; Waters NC
    Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):95-114. PubMed ID: 18221166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antimalarial resistome - finding new drug targets and their modes of action.
    Carolino K; Winzeler EA
    Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drugs against malaria: What's in the pipeline? Little new in the fight against malaria].
    Schlitzer M
    Pharm Unserer Zeit; 2009; 38(6):522-6. PubMed ID: 19862720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.